1648P Final clinical and liquid biopsy (LBx) results of phase II trial of sacituzumab govitecan (SG) in patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) progressing on androgen receptor signaling inhibitors (ARSI)Joshua M. Lang, Christos E. Kyriakopoulos, S.T. Tagawa et al.|Annals of Oncology|2024Cited by 7
2419P Clinical consequences of therapy related clonal hematopoiesis in patients treated with PSMA- targeted radionuclide therapyPinkal Desai, S.T. Tagawa, Rohit Joshi et al.|Annals of Oncology|2025Cited by 1